GPs key to opening up ‘fortress Australia’ The re-opening of international borders is inevitable, but first GPs need help to combat COVID complacency and vaccine hesitancy.
What is needed to get Australians vaccinated by December? Completing the vaccination program in 2021 is plausible, but GPs say additional funding and delivering mRNA vaccines will be crucial to utilising general practice’s ‘untapped capacity’.
No obvious barriers for GP involvement in potential Moderna rollout Existing infrastructure should allow general practices to take part in the administration of up to 25 million doses of the mRNA COVID vaccine once it is approved for use in Australia.
Evidence suggests AstraZeneca and Pfizer are equally effective Experts say the research is reassuring, and indicates that both COVID vaccines offer a pathway to Australia reaching a high level of immunity.
National vaccine program key driver in reduced COVID cases: Study Real-world data has added further weight to the potential public health benefits of mass-vaccination against the coronavirus.
Vaccine rollout funding reform headlines RACGP advocacy agenda The college continues to call for additional MBS item numbers to support vaccine counselling in general practice.
Experts say vaccine patent waiver key to ending global pandemic As the pandemic continues to rage in many parts of the world, Australia is among the developed nations yet to formally support the proposal to help ensure equitable access to COVID vaccines.
Australians ‘highly concerned’ about COVID vaccine side effects Though there has been a recent uptick in people who say they would get a ‘safe and effective’ vaccine, according to a new survey.
GPs’ AstraZeneca supply to be increased immediately Practices will now receive an additional 150–200 doses each week.
Promise wanes for mRNA onshore production With local manufacturing of mRNA vaccines looking increasingly slim in the short term, where does that leave Australia?